Skip to main content

Duration of Follow Up for New Molecular Entities Approved in 2017: First Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    new molecular entities (NMEs)
    Description

    The purpose of this analysis was to investigate the duration of follow-up time available for users of New Molecular Entities (NMEs) approved in 2017, stratified by age, sex, and calendar year, in the Sentinel Distributed Database (SDD). This analysis includes two reports:

    • Report 1: We investigated the duration of follow-up time available for users of 23 NMEs approved between January and June of 2017. We distributed this request to 16 Sentinel Data Partners on March 19, 2020.
    • Report 2: We investigated the duration of follow-up time available for users of 25 NMEs approved between July and December of 2017. We distributed this request to 16 Sentinel Data Partners on March 20, 2020.